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F. tularensis is a zoonotic agent and the subspecies novicida is proposed to be a water-
associated bacterium. The intracellular pathogen Francisella tularensis causes tularemia in 
humans and is known for its potential to be used as biological threat. We analyzed the genome 
sequence of F. tularensis subsp. novicida U112 in silico for the presence of a putative 
functional CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic 
Repeats/CRISPR-associated) system. CRISPR/Cas systems are known to encode an RNA-
guided adaptive immunity-like system to protect bacteria against invading genetic elements, 
like bacteriophages and plasmids. In this work, we present a first indication that F. tularensis 
subsp. novicida encodes a functional CRISPR/Cas defence system. Additionally, we 
identified various spacer DNAs homologous to a putative phage present within the genome of 
F. tularensis subsp. novicida-like strain 3523. CRISPR/Cas is also present in F. tularensis 




 Francisella tularensis is an intracellular pathogen that causes tularemia in humans and 
a wide range of animals (Ellis et al., 2002). Furthermore, F. tularensis is well known for its 
potential as a bacterial biological weapon (Dennis et al., 2001). Strains of F. tularensis subsp. 
(Ft.) tularensis can be lethal to humans and doses as low as 10-20 bacteria can be infective 
(Ellis et al., 2002). Transmission can mostly occur via aerosol ingestion or skin inoculation. 
Ft. novicida is less virulent and is thought to be an opportunistic pathogen. There are some 
reports of human infections by Ft. novicida, mostly these reports were from 
immunocompromised patients. The infection was localized and showed a relative mild illness 
(Clarridge et al., 1996; Hollis et al., 1989). However, Ft. novicida is thought to constitute an 
environmental lineage along with F. philomiragia. F. philomiragia has also been rarely 
associated with human disease in immunocompromized individuals (Hollis et al., 1989; 
Wenger et al., 1989).  
 Ft. novicida strain U112 is a water isolate from 1950 (Larson et al., 1955). There are 
further reports of several Ft. novicida-like bacteria isolated from humans (Birdsell et al., 
2009; Clarridge et al., 1996; Hollis et al., 1989; Leelaporn et al., 2008; Whipp et al., 2003). 
The genome sequences of strain U112, the clinical isolate 3523 (Australian strain) and Fx1 
(Texas strain) are available, as well as some Ft. tularensis and F. philomiragia strains 
(Barabote et al., 2009; Beckstrom-Sternberg et al., 2007; Champion et al., 2009; Chaudhuri et 
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al., 2007; Larsson et al., 2005; Modise et al., 2012; Nalbantoglu et al., 2010; Petrosino et al., 
2006; Rohmer et al., 2007; Siddaramappa et al., 2011; Sjodin et al., 2012; Zeytun et al., 
2012). Ft. tularensis is a highly infectious zoonotic agent. For Ft. novicida it is proposed to be 
a water-associated bacterium, but the environmental reservoir and the mechanism of 
transmission of Ft. novicida along vertebrate or invertebrate species is unknown. Francisella 
isolate 3523 is the first reported Francisella strain from the Southern Hemisphere, isolated 
from a patient infected by brackish water in the Northern Territory of Australia (Whipp et al., 
2003). 
 
 Environmental bacteria easily get in contact with invading genetic elements, such as 
bacteriophages and plasmids. Bacteria have evolved an RNA-guided adaptive immunity 
mechanism to protect themselves against these invaders (Deveau et al., 2010; Horvath and 
Barrangou, 2010; Karginov and Hannon, 2010; Kunin et al., 2007; Makarova et al., 2011a; 
Makarova et al., 2011b; Sorek et al., 2008; van der Oost et al., 2009; Wiedenheft et al., 2012). 
The CRISPR/Cas system (Clustered Regularly Interspaced Short Palindromic Repeats/ 
CRISPR-associated) uses repeat/spacer-derived short CRISPR RNAs (crRNAs) to silence 
foreign nucleic acids in a sequence-specific manner. It targets the invading phages or 
plasmids in three steps: (1) adaptation of short pieces of DNA homologous to virus or plasmid 
sequences (spacers) into the CRISPR locus, (2) expression and processing of short guide 
crRNAs consisting of unique single repeat-spacer units and (3) interference with the alien 
nucleic acid by the activity of the proteins encoded by the cas genes. The hypothesis that the 
CRISPR/Cas system is necessary for the defence against invading DNA has been 
demonstrated in Streptococcus thermophilus. The integration of a short phage-specific 
sequence into the CRISPR locus of the strain conferred resistance to the cognate phage 
(Barrangou et al., 2007). The CRISPR/Cas system is divided into three distinct types (I, II and 
III). The signature genes for the three types are cas3, cas9 and cas10, respectively (Makarova 
et al., 2011a; Makarova et al., 2011b).  
 
 In this paper we describe two different CRISPR/Cas systems identified within the 
genome of Ft. novicida U112 and the presence of these CRISPR systems in other Francisella 
strains. We present a first indication that the CRISPR/Cas systems of Ft. novicida encode 
functional defence systems by the identification of various spacer DNAs, homologous to a 




Materials and methods  
CRISPR search in the genomes 
 Genome sequences used for in silico analysis are given in Table 1. CRISPR sequences 
in the genome of Ft. novicida U112 were identified by using the CRISPRFinder software 
(Grissa et al., 2007). Organization of the CRISPR/Cas systems of the strains investigated was 
analysed by using the software ARTEMIS (http://www.sanger.ac.uk/resources/software/ 
artemis/). The CRISPR/Cas system (genes, proteins, direct repeats and spacer DNAs) of Ft. 
novicida U112 was used to identify homologous CRISPR/Cas systems within the analyzed 




Results and discussion 
 
Identification of two CRISPR/Cas systems in F. tularensis subsp. novicida U112 
 We used the "CRISPRFinder" software of the CRISPR database (CRISPRdp, 
http://crispr.u-psud.fr) for in silico analysis of the genome sequence of Ft. novicida U112 and 
identified four putative CRISPR systems. Two of them exhibit several direct repeats. For 
these two genomic regions, we also identified the presence of putative cas genes. Therefore, 
we further investigated the surrounding chromosomal DNA regions. 
 In Figure 1A, the CRISPR/Cas-1 system of Ft. novicida U112 is illustrated. The first 
gene FTN0757 encodes a Cas9 homolog. Cas9 represents the signature protein of the CasII-B 
type of cas genes (Makarova et al., 2011b). The cas gene order (cas9-cas1-cas2-cas4) is also 
similar to the CasII-B type of CRISPR systems (Makarova et al., 2011a; Makarova et al., 
2011b). Cas1 and Cas2 proteins are involved in spacer DNA acquisition (see below), as well 
as Cas4, which is also thought to be involved in this process (Beloglazova et al., 2008; 
Makarova et al., 2011a; Makarova et al., 2011b; Wiedenheft et al., 2012). Downstream of 
cas4, a leader sequence of 359 bp, known to be necessary for spacer acquisition (Makarova et 
al., 2011a; Makarova et al., 2011b) and a direct repeat sequence are present in the CRISPR-1 
system of Ft. novicida U112. It is proposed that the first repeat is the template for newly 
inserted repeats. In this process, the new repeat is replicated from repeat #1 (Yosef et al., 
2012). The system of Ft. novicida U112 exhibits 13 spacer sequences of about 35 bp (34-37 
bp) and all repeat sequences (37 bp in length) of the system are identical (Fig. 2A). This 
indicates that the CRISPR-1 system is functional, since spacer acquisition is present. The 
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spacer sequences are discussed later (see below). DNA sequences of the leader, the repeats 
and the spacers are given in Figure 2A.  
 
 In Figure 1B the CRISPR/Cas-2 system of Ft. novicida U112 is shown. As for the 
CRISPR/Cas-1 system, all putative necessary cas genes (FTN1397 [cas9-like], cas1, cas2 and 
cas4), a leader sequence (139 bp), the first direct repeat (36 bp) and spacers of about 29 bp 
(26-32 bp) are present. The sequences of the leader and the spacers are given in Figure 2B. 
The repeats of the system are identical, with the exception of the last repeat (Fig. 2B). 
However, FTN1397 exhibits no Pfam_domain or motif, thus a putative Cas9-like function is 
proposed from the size and localisation of the gene. In additon, the cas gene order (cas4-cas1-
cas2) is similar to the gene order found in type I-(A-D) CRISPR systems (Makarova et al., 
2011a; Makarova et al., 2011b). Since cas9 is thought to be the type signature gene, the cas 
type (I, II, or III) of the CRISPR-2 system of Ft. novicida U112 is unclear. However, since 
nine spacers are present (see also below), CRISPR/Cas-2 of Ft. novicida U112 also seems to 
encode a functional CRISPR system.  
 
Presence and organization of CRISPR-1 and CRISPR-2 in other Francisella strains 
 We then analysed various available genome sequences of Francisella (see Tab. 1) for 
the presence of CRISPR-1 and CRISPR-2. The six investigated Ft. novicida-like strains are 
positive for CRISPR-1 and only the strains GA99-3548 and 3523 are negative for CRISPR-2. 
The genome sequences of Ft. tularensis, Ft. holarctica and Ft. mediasiatica exhibit a 
CRISPR-1, but no CRISPR-2 system (Tab. 1). Only one strain of F. philomiragia 
(ATCC25017) is postive for the CRISPR-2 system (Tab. 1). Then we had a closer look at the 
organization of the CRISPR-1 and -2 systems of the above mentioned strains.  
 The results for the CRISPR/Cas-1 system are shown in Figure 3. The CRISPR/Cas-1 
system is localized directly downstream of the fopA gene. The outer membrane protein Fop A 
is known as a protective antigen for tularemia and the conserved fopA gene is used in 
diagnosis of tularemia using PCR and real-time TaqMan PCR assays (Fulop et al., 1996a; 
Fulop et al., 1996b; Hickey et al., 2011; Versage et al., 2003).  
 In all Ft. novicida strains investigated, the last direct repeat is followed by a gene 
homologous to FTN0761 of strain U112. All five strains exhibit a similar cas-gene 
organization with ~99% DNA identity to U112, with the exception of strain Ft. novicida 
3523. In this strain, the leader sequence is different (90% DNA identity) and the direct repeat 
is not identical to that of strain U112 (Fig. 3 and 4). All strains exhibit different numbers of 
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spacer DNAs (Fig. 3). Interestingly, Ft. novicida strains Fx1 and GA99-3548 exhibit various 
spacer DNAs, although they possess a deletion within the cas gene region. Gene cas2 is 
deleted and genes cas1 and cas4 are partially deleted. In strain GA99-3549 an IS element is 
integrated into the cas4 gene. Therefore it is unclear, if the CRISPR system still encodes a 
functional CRISPR system. However, they may encode functional systems, since they exhibit 
various spacer DNAs and it was published that Cas9 seems to be sufficient for the generation 
of crRNA and cleaving of the target DNA (Barrangou et al., 2007; Deltcheva et al., 2011; 
Makarova et al., 2011a; Makarova et al., 2011b). In all other strains investigated, IS-Ftu2 was 
found downstream of the single (#1) direct repeat and these CRISPR systems do not exhibit 
any spacer DNAs, indicating that the identified CRISPR/Cas-1 systems of these strains are 
non-functional (Fig. 3). Nevertheless, the leader sequence is still present and identical to that 
of strain U112 (Fig. 4). 
 In the analysed Ft. tularensis strains, the cas9 and cas4 genes are present, but cas1 and 
cas2 genes are pseudogenes genereated by various point mutations (Fig. 3). In the three Ft. 
holarctica strains FSC022, FSC257 and LVS, the cas9 gene is separated into three to four 
genes which encode putatively functional proteins. These strains also exhibit a complete cas4 
gene and various point mutations within the cas1 and cas2 genes. However, in strain LVS 
cas2 seems to encode a putative functional protein. In Ft. mediasiatica FSC147, only cas2 
seems to encode a putative functional protein, all other cas genes are pseudogenes (Fig. 3). 
Within the genomes of the three F. philomiragia strains (ATCC25017, ATCC25015 and 
TX077308) investigated, no CRISPR-1 system could be identified and no CRISPR-like 
region could be identified downstream of fopA (F. philomiragia ATCC25017, see Fig. 3). 
 The results for the CRISPR/Cas-2 system are shown in Figure 5. The CRISPR/Cas-2 
system is localized downstream of a gene (FTN1398) encoding an acetyl transferase (AcTF) 
and upstream of arsR (FTN1393) encoding a regulatory protein. All CRISPR/Cas-2 systems 
exhibit a similar cas gene organization, a leader region exhibiting 96-100% DNA identity to 
strain U112 and identical direct repeats, except the last direct repeat (Fig. 4B and Fig. 5). In 
contrast to CRSIPR-1, in CRISPR-2 the last direct repeat (#L) differs from the others, but is 
similar among the different CRISPR-2 systems analysed (Fig. 4B). This is surprising, since it 
is thought that all repeats are replicates of repeat #1 (Yosef et al., 2012). All CRISPR-2 
systems identified seem to be functional, since they exhibit different amounts of spacer DNAs 
(5-18 copies). Like cas9 in the CRISPR-1 system of the Ft. holarctica strains LVS and 
FSC257, the hypothetical signature protein of CRISPR-2 of F. philomiragia seems to be 
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separated into three open reading frames (Fphi1650-52) which seem to encode functional 
proteins, since the CRISPR-2 system of this strain exhibits five spacers (Fig. 5).  
 The CRISPR-2 system is present in all Ft. novicida strains investigated and is 
integrated within the same chromosomal region, with the exception of strain Ft. novicida-like 
3523 (Fig. 5). In strain Ft. novicida-like 3523 there is no DNA insertion between the AcTF 
and the asrR gene. However, downstream of AcTF a #L repeat was detected and in GA99-
3548 a #1 repeat-spacer-#L repeat structure is present, indicating the loss of a prior 
CRISPR/Cas system. CRISPR-2 is also present in F. philomiragia ATCC25017, but is 
located at another genomic region. In F. philomiragia ATCC25017, two F. philomiragia 
specific genes are located between AcTF and argR (Fig. 5). We were not able to detect a 
homolog of CRISPR-2 in F. philomiragia strains ATCC25015 and TX077308 as well as in 
any of the investigated available genome sequences of Ft. subsp. tularensis, holarctica or 
mediasiatica (Fig. 5 and Tab. 1). In Ft. holarctica LVS and Ft. tularensis SchuS4, an IS-Ftu1 
element is integrated between repeat #1 and repeat #L, but no further elements of the 
CRISPR/Cas system are present (Fig. 5). In Ft. mediasiatica, a chromsosmal rearrangement 
has occured in the respective region, probably caused by a recombination event of two IS-
Ftu1 elements. The loss of genes may be a process of genomic pathoadaptation in response to 
changing or new habitats of the bacteria (Champion et al., 2009; Ochman and Moran, 2001; 
Svensson et al., 2005). The CRISPR/Cas system may be more relevant for the water-
associated species Ft. novicida and F. philomiragia, which gets in contact with a large 
number of different (invading) mobile genetic elements. 
 
Analysis of the spacer DNAs of the CRISPR-1 and CRISPR-2 systems 
 The CRISPR/Cas system is an adaptive immunity-like system found in many bacteria 
(Makarova et al., 2011a; Makarova et al., 2011b). Bacteria are able to integrate short pieces of 
DNA, often homologous to virus or plasmid sequences, into the CRISPR locus (see 
introduction). The locus is then transcribed (pre-crRNA) and cleaved into short crRNAs. This 
step is catalyzed by the cas genes and directs interfering proteins to target nucleic acids 
matching the spacers. In S. thermophilus this system was shown to confer resistance of the 
bacteria to specific phages (Barrangou et al., 2007). The spacer DNA in general is very 
specific for each strain and therefore used for epidemiological subtyping (spoligotyping) 
(Ginevra et al., 2012; Price et al., 2007; Sorek et al., 2008). Since Ft. novicida and F. 
philomiragia are species known to be associated with aquatic habitats and therefore may get 
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into contact with various phages and plasmids, we had a closer look to the spacer DNA of the 
identified CRISPR systems. 
 The spacer DNAs of CRISPR-1 and CRISPR-2 are 34-38 and 26-33 bp in length, 
respectively. Results of "Blastn" searches with the spacer DNAs of the CRISPR-1 and 
CRISPR-2 systems are listed in Table 2. Interestingly, we found spacer DNAs with counter 
parts in a sequence of a phage minor tail protein (Ft. novicida-like 3523, CRISPR-1, 1. 
spacer), a Vibrio phage ICP1_2004_A sequence (Ft. novicida GA99, CRISPR-2, 2. spacer), 
of a plasmid of Vibrio harveyi (Ft. novicida U112, CRISPR-2, 8. spacer) and in F. 
philomiragia a spacer DNA sequence in antisense direction to an own gene (Fphi1603) (F. 
philomiragia 25017, CRISPR-2, 1. spacer). In one case, a part of spacer 11 of Ft. novicida 
U112 CRISPR-1 is also found (in antisense direction) in spacer 7 of Ft. novicida GA99-3549 
(Tab. 2). This indicates that the CRISPR systems of these strains are functional, since the 
bacteria acquired spacers during their life-cycle, the predicted function of CRISPR/Cas 
systems. However, the most intriguing finding was the identification of altogether 12 spacer 
sequences, in both CRISPR systems of 5 different species, which all also were identified 
within the same chromosomal region of strain Ft. novicida-like 3523 (Tab. 2, underlined 
sequences and Fig. 6A, red arrows).  
 We therefore had a closer look to that DNA region of strain Ft. novicida-like 3523 and 
we identified a putative genomic island of about 34,259 bp exhibiting 48 open reading frames 
(ORFs) (Fig. 6A). Most of the encoded proteins are homologous to phage proteins (phage tail, 
phage major tail tube, tail sheath, base plate, tail fiber, phage terminase, coat protein, 
replication protein and regulatory proteins) and therefore, this genomic island may encode a 
Ft. novicida phage (Fig. 6B). The phage island is integrated into the tRNA
Val
 (localized 
between gene FN3523_0985 and _0986) and the corresponding attL-site (repeat-1, Fig. 6A) is 
localized between FN3523_1033 and FN3523_1034. Gene FN3523_1033 encodes a site-
specific integrase with 31% identity to Lpc2818, a site-specific integrase of the genomic 
Island Trb-1 of L. pneumophila Corby. In L. pneumophila Trb-1 is also integrated into a 
tRNA (tRNA
Pro
) gene and the integrase (Lpc2818) is responsible for the generation of a 
circular episomal form of Trb-1, which then can be transferred to other Legionella strains by 
conjugation (Glockner et al., 2008 and unpublished data). Therefore, it is likely that the phage 
of Ft. novicida-like 3523 may be excised from the genome in a circular form. In addition, 
gene FN3523_1028 encodes a putative pro-phage repressor and gene FN3523_1021 an phage 
anti-repressor (of the circular form). Due to the lack of chromosomal DNA of this strain, we 
could not prove this hypothesis so far, but it will be of interest to further analyse this putative 
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phage. Gene FN3523_1034 encodes an HlyD-like protein, recently described to be part of a 
toxin encoding locus of Ft. novicida-like 3523 (Siddaramappa et al., 2011).  
 Surprisingly, this putative phage is found within the genome of a Ft. novicida-like 
isolate of Australia (Siddaramappa et al., 2011). However, the spacer DNA was identified in 
isolates of Ft. novicida U112 (Utah, USA), GA99-3548 (Louisiana, USA), GA99-3549 
(California, USA) and in Ft. novicida Fx1 (Texas, USA). This indicates that this phage may 
be a general (ubiquitous) phage of Ft. novicida strains. Therefore, we called it a Ft. novicida 
phage. The spacers identified covered the 5`-part of the phage (Fig. 6A, red arrows). The 
complete region is shows low similarity to a lytic E. coli phage (vB_EcoM_ECO1230-10) 
isolated from diary farms manure systems (Santos and Bicalho, 2011). 
 
Conclusion 
 In this work, we provide a first indication for functional CRIPSR/Cas systems in F. 
tularensis subsp. novicida and one strain of F. philomiragia, since various different spacer 
sequences are present within the identified systems. We also found a first hint for a general 
Francisella phage-targeting sequence within the analysed spacer DNAs and we identifed the 
corresponding putative phage within the genome sequence of Ft. novicida-like strain 3523. So 
far, other natural phages for F. tularensis are unknown. Interestingly, the evolutionarily oldest 
and water-associated Ft. novicida strains (Svensson et al., 2005) exhibit functional 
CRISPR/Cas systems, whereas the more virulent and evolutionary younger strains Ft. 
tularensis, holarctica and mediasiatica seem to carry inactive CRISPR/Cas systems, 
exhibiting various gene deletions or pseudogenes. Similar findings were also published for the 
whole genome sequences of these strains (Champion et al., 2009). This process may be an 
adaptation of the strains to new habitats (e.g., like eukaryotic hosts) (Dobrindt et al., 2010; 
Ochman and Moran, 2001).  
 For other bacteria, the spacer DNAs of the CRISPR/Cas systems are used for 
epidemiological subtyping of isolates (spoligotyping) (Ginevra et al., 2012; Price et al., 2007; 
Sorek et al., 2008). It would be interesting to analyse, if the CRISPR/Cas system is usable to 
generate a CRISPR/Cas spacer based spoligotyping for Francisella. 
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Fig. 1. Organization of the CRISPR/Cas-1 (A) and CRISPR/Cas-2 (B) systems of Ft. novicida 
U112. The cas genes are indicated by grey arrows, gene numbers are given above and gene 
names and numbers of amino acids (aa) are given below. The leader (black line), the direct 
repeats (red arrows) and the spacers (blue arrows) are shown. The number of spacers are 
indicated above the blue arrows. #1, first repeat; #L, last repeat. 
 
Fig. 2. Nucleotide sequence of the CRISPR-1 (Leader: 359 bp, DR: 37 bp; 13 spacers) (A) 
and CRISPR-2 (Leader: 139 bp, DR: 36 bp, 9 spacers) (B) region of Ft. novicida U112. The 
DNA sequence of the leader (green), the direct repeats (red), the spacers (black) and other 
chromosomal DNA (brown) are given.  
 
Fig. 3. Organization and comparison of the CRISPR/Cas-1 systems of different Francisella 
strains. In all strains investigated, the system is integrated downstream of fopA. The cas genes 
are indicated by blue arrows, gene numbers are given within and gene names above the blue 
arrows. The leader (black line), the direct repeats (red arrows) and the spacers (brown arrows) 
are shown. The number of spacers are indicated below the brown arrows. DNA identity (%) 
of the cas gene encoding regions and the leader DNAs to the respective DNA region of F. 
tularensis subsp. novicida U112 (Ft. nov U112) is given. An IS element and IS-Ftu2 are 
indicated by an orange and yellow arrow, respectively. Homologous genes are shaded in the 
same colour. Variations in the amino acid length of ORFs or the leader sequence are given in 
brackets. *Identical DNA sequences were identified in strains Ft. tularensis FSC198, 
NEO61598, TIGB03, TI0902 and MA00-2987. aa, amino acids; bp, base pairs; n.a, not 
annotated; ps, pseudogene; nov, novicida; hol, holarctica; med, mediasiatica; phi, 
philomiragia. 
 
Fig. 4. DNA sequences of the direct repeats (DRs) of the CRISPR/Cas-1 and -2 systems. nov, 
novicida; tul, tularensis, hol, holarctica; med, mediasiatica, phi, philomiragia; GA99-48/-49, 
GA99-3548/49. #1, first repeat; 2., second repeat; #L, last repeat, (-), nucleotide not present; 
(.) , identical nucleotide; (*), strain does not exhibit a CRISPR/Cas-2 system.  
 
Fig. 5. Organization and comparison of the CRISPR/Cas-2 systems of different Francisella 
strains. The cas genes are indicated by grey arrows, gene numbers are given within and gene 
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names above the arrows. The acetyl transferase (AcTF)-arsR-naoX gene cluster is shaded in 
blue and a F. philomiragia specific gene cluster in brown. Numbers of amino acids are given 
in brackets. The leader (black line), the direct repeats (red arrows) and the spacers (yellow 
arrows) are shown. The number of spacers are indicated below the yellow arrows. DNA 
identity (%) of the cas gene encoding regions and the leaders to the respective DNA region of 
F. tularensis subsp. novicida U112 (Ft. nov U112) are given. The IS element IS-Ftu1 is 
indicated by green arrows. * Similar organization of the respective DNA region was observed 
for strains Ft. tularensis FSC198, NEO61598, TIGB03, TI0902 and Ft. holarctica OSU18. 
aa, amino acids; bp, base pairs; nov, novicida; hol, holarctica; med, mediasiatica, phi, 
philomiragia; GA-49, GA99-3549. 
 
Fig. 6. Organization of the putative Ft. novicida phage (A) and details of all open reading 
frames (ORFs) present (B) identified within the genome sequence of F. tularensis subsp. 
novicida-like strain 3523. (A) The putative phage (34,259 bp, 48 ORFs) is integrated within 
the tRNA
Val
 gene (yellow arrow). The 3`end of the tRNA
Val
 gene, which is conform with 
repeat-1, is indicated as a yellow trapezium. Hypothetical proteins of the putative phage are 
shown in grey and genes with similarities to known phage proteins are shaded in blue. A 
putative site-specific integrase is indicated by an green arrow. Location of the spacer DNAs 
identified in the CRISPR/Cas-1 or -2 systems of analysed Francisella strains are indicated by 
red arrows. The sequence of the tRNA
Val
 gene and of repeat-1 are shown below. (B) Gene 
designation, length of the proteins (aa) and putative function of all 48 open reading frames 
(ORFs) of the putative phage are given. black, hypothetical proteins; blue, proteins with 
similarities to known phage proteins; red, ORFs exhibiting nucleotide sequences identified as 
spacers within the CRISPR/Cas-1 or -2 systems of analysed Francisella strains; aa, amino 





Table. 1 Genome sequences (species) used for CRISPR/Cas analysis 
Species Acession number CRISPR-1 CRISPR-
2 
Ft. novicida U112 CP000439 + + 
Ft. novicida FTG ABXZ01000001* 
ABXZ01000002* 
+ + 
Ft. novicida-like Fx1 CP002557 + + 
Ft. novicida-like GA99-3548 DS264589* 
DS264590* 
+ - 
Ft. novicida-like GA99-3549 DS264128* 
DS264129* 
+ + 
Ft. novicida-like 3523 CP002558 + - 
 
Ft. tularensis SchuS4 AJ749949 + - 
Ft. tularensis FSC198 AM286280 + - 
Ft. tularensis MA00-2987 DS990216* + ni 
Ft. tularensis WY96-3418 CP000608 +  - 
Ft. tularensis NE061598 CP001633.1 + - 
Ft. tularesnsis TIGB03 CP003048 + - 
Ft. tularensis TI0902 CP003049 + - 
Ft. holarctica LVS NC_007880 + - 
Ft. holarctica  FSC257 DS229056* + ni 
Ft. holarctica FSC022 DS264138* + ni 
Ft. holarctica FTNF002-00 CP000803 + - 
Ft. holarctica OSU18 CP000437 + - 
 
Ft. mediasiatica FSC147 CP000915 + - 
 
F. philomiragia ATCC25017 CP000937 - + 
F. philomiragia ATCC25015 DS99316* - - 
F. philomiragia TX077308 CP002872 - - 
F. noatunensis subsp. orientales CP003402 - - 
* contigs of shot gun sequences received from NCBI/GenBank/ "DBSource" 




Table 2. Spacer sequences of CRISPR-1 (A) and CRIPR-2 (B) systems of various Francisella 
strains. 
 
A. CRISPR-1       Blastn (>25 bp in length) 
 
Ft .novicida U112 (34-37 bp)    
1. caagattggtatatatcaactgctaatcactcgc  - 
2. ggtaaaaccaaaaaccaaaagttaagatatctctt  - 
3. tatgcggcttgtggttgtgtcattgcgaagactg  - 
4. ttaagcggatcaatttcgattacatcttcaccagat  - 
5. tttgtcaaatattggtcgagttatcttaaatagt  Nostoc punctiforme pNPUN03 
6. actcctatatgaccatacaaaacctgcccattac  - 
7. ttatttgccaacactcaaaagataggtaaccctatag  - 
8. tagttttttattatctgtgctgttttctgtcattgc  - 
9. gtatatatcagtagtttaaaagcattggctattact  - 
10.gttaataatgctaaagaaccagctgaatgtgtaa  - 
11.attcttgaattaagtgttgctgctgaggattaggca  antisense of spacer 7 of Ft.
        nov. GA99-3549 (CRISPR-1)* 
12.atataaatttggataattttaaggtattaaatcctt  - 
13.atcacactataaaagtaatcaagcttgccattgt  - 
 
Ft. novicida Fx1 (34-37 bp) 
1. tctggatgtagtaaccaagtcttacgctcgataa   - 
2. gttggatctgtctctctcattaatacaagattgtat  - 
3. aataaagaaaatgtagacttattccaaaacgtta  - 
4. agcttctcatatatgtatttactgtcgatttgat  - 
5. ttttaataggtgatttgtgaattttgatgagttaaag  - 
 
Ft. novicida FTG (34-38 bp) 
1. aagtttgacttgttaccctttgaatttcatctcta  - 
2. tcaatataccagctaggattactcgcataagcat  - 
3. taatgcaaatttgtatagtctacttctgtagaataa  Xenopus tropicales mRNA, 
        Homo sapiens DNA 
4. agtattttctcttgtcttgtaagttctcttagatag  FN3523_0993 
5. taagaaacttcgtcggttcttgggtactatgtacta  - 
6. agtattcttgacgcggctactaatacgtatcaaataaa Flavobacterium   
        branchiophilum 
7. taaagcactctctaagatgacttcataattactac  - 
8. aacgatattacacgcgaaagagctgcttttgagat  FN3523_1002 
9. taagcaagactctcaaacagactttaaagcatcgttt  - 
10.gctctatttaagtgttcgtgatactctgtttgtaa  - 
11.acaagctaaagaaattattataattgcttactaca  - 
12.tagcaagtattagtttacttcatttatttaaaat  - 
13.agattatgtgtaagcaacttaattttaacgaacttc  - 
14.atctaattggtaactcggaaagtataatcattg  - 
15.acccaaataatctcgttatcatgaggctttatttg  - 
16.tcctgaaatttccactggtctcccaagaaagcttg  - 
17.ccgtatttagcctaatgttatctttaaatatttcaa  - 
18.aagaattaaaacaagaaagcatgtaacaaacttagat  M.truncatula DNA 
19.ctctttcttcccctttctgcttgtcgctcaataaa  - 
20 ttattagaaaaaataaatgctggtatgttaaaattcg  Homo sapiens DNA 
21.atcatagaagctaaatatagcggtaaaatgtttga  - 
22.ctctttcttcccctttctgcttgtcgctcaataaa  - 
 
Ft. novicida 3523 (34-37 bp) 
1. ttgccagtataaccaccttcagcaaaaccagtaaca  Acinetobacter baumannii 
        phage minor tail protein* 
2. gccaaaaagactgagcctaaggctaaagttgagg  - 
3. gtaataacagcctttgagcctttacagcctacaa  - 
4. ccagcactatctgcaattgcaatgttgctttggt  - 
5. attaaaaaagaaatatatgctgtatcgtatggca  - 
6. catataacctgaattgtacccgtatcggcagcag  - 
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7. ttttttttatttgttttgcctgcaatgctcatagca  - 
8. taacgcctcgaagttgaactttataacccaatatag  - 
9. ttcatctaaccaatccccataatcgttccataattg  - 
10.tcgacatactcttgatattcattatctggcttaa  - 
11.aatatcgctagaaaacatattgttaagcatattat  - 
12.ccgtttcaacaacaggcttgaagtttcaagcact  - 
13.tcaccctcgccgccagtttgaccgcctccaccag  Symbiobacterium thermophilum 
14.aattgtgaaatagataatatagcttctacattaga  Mus musculus BAC clone 
15.ataaaaattaaataaaatatcttgaaatgcttatt  Felis catus 
16.agagaatttgtatttagataccctaagattaagaaaa  - 
17.tctggacgagtgttggttatagtcattgtcatacc  - 
 
Ft. novicida GA99-3548 (35-37 bp) 
1. tcgacaggagtctgaccgtcaattaaagcagataatc  - 
2. taggatttacgccagctaattcgttaactaggttca  - 
3. gaactcgtcgtacatgatctccgccgccatgtgcag  - 
4. cgctactataaataggggcggatataataaccgaa  - 
5. ttcatcagcgaatcttttaaatttcttagatttgtca  - 
6. gtacaaagagtttatttctcgtgttactttttttatt  Mus musculus BAC clone 
7. gcccaaattttctgctcaaattcgccttttttgcg  FN3523_0999 
8. tatcttcaatatacaaatcaatataagagttatct  FN3523_1006 
9. ctatattcaaacttgcatatatttctgatagggct  FN3523_1009 
10.attaattgcactagagaagcaagtccgaatctcggg  - 
 
Ft. novicida GA99-3549 (34-36 bp) 
1. aagatagacagagctttattacaatcaagaaaagat  - 
2. ccagttacgttatcgtctcgcactatcgcaggag  - 
3. aatcatagagttaatttcgctcctgaccctgctg  - 
4. tgattaataacacgataaacattacctttttgtttt  - 
5. aatgattaaaatctacgaaactgatactcaaattc  - 
6. agttgcctcgaatcgttccagcagatgtaaacat  - 
7. aacccgcaacagcaacacttaattcaagagttgg  antisense spacer 11 Ft. nov 
        U112 (CRISPR-1)* 
8. aaatctaaaaaatgtagattaataccaatacagcaa  B. subtilis plasmid 
 
 
B. CRISPR-2        Blastn (>22 bp in length) 
 
Ft. novicida U112 (26-32 bp)  
1. gagaagtcatttaataaggccactgttaaaa   - 
2. gctactattcctgtgccttcagataattca   Strongylocentrotus  
        purpuratus 
3. gtctagagccttttgtattagtagccg   - 
4. tagcgatttatgaaggtcattttttt    intergenic region  
        (FN3523_1004-5) 
5. agattaaaaggtaattctatcttgttgag   FN3523_0998 (antisense) 
6. tacctagtagatacgcttactgataacaa   - 
7. aaactttcatttatgatataaagtttttt   Apis mellifera, mRNA 
8. tcaaaaggcaagagagacggaaataaatggac   Sisymbrium irio, V. harveyi 
        plasmid 
9. ttgtttgattgcttgcattgaaccttgaa   16S rRNA 
 
Ft. novicida Fx1 (28-29 bp)  
1. gccatctcttcataataaccactccaaa   - 
2. taacatatggactggcatattcttccaa   - 
3. ctaacgtagcgtaataaccagtaagtagg   - 
4. ataagggtacgttcggtcaaatagctact   - 
5. aaacacttctgtcgttttttcaaacattt   - 
6. atggattattacttaactggagtgtttac   Fn 3523_0992  
 
 
Ft. novicida FTG (27-30 bp)  
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1. tttttgtgtatgtaatgtagctttcttta   - 
2. atggttgtctaggtagtgtaaattccat   - 
3. aagcagctgcttatgttttgacaatcaaa   - 
4. tcaataaaaaatgcccattgactaacgg   - 
5. atattgttttaaatcgtcgctatcagcaaa   - 
6. caaatatagctaacttttggaactcag   - 
7. tctattatgtttcctgaaagagtagtttt   Naegleria gruberi, mRNA 
8. gccacaaatactacaaaaaataacttaa   FN3523_1005 
9. ctaggcttggaatatctgtcagagata   - 
 
Ft. novicida GA99-3549 (28-33 bp)  
1. ggctttctttagcttcttctagagtttt   C. perfringens purD 
2. atataactatcaccagcaatctgtacgag   Vibrio phage ICP1_2004_A 
3. taaaatggttgtttagttatgtcagaaat   Rattus norvegicus BAC clone 
4. aatttacgccgtatttcatttcatctcc   Drosophila melanogaster 
5. gcagagatcattaaaccaatagcacagc   - 
6. tctgtagaaattcctagtttttgagatg   Homo sapiens 
7. ggctcaagtaatatcaataatttagaat   - 
8. atttatgtgatgactggtgttgctaatg   - 
9. acaattatatccatcacatacccctctaa   Aciduliprofundum boonei 
10.tgtattttagataggtttcagcagaaat   - 
11.agtgcttaagaaaatcgaaagtatttggg   - 
12.tataatgaaaatacgattattacttagaag   - 
13.attgtcaaaacataagcagctgcttcaaatat   FN3523_1009 
14.gtcgctttatcatctttatactccttaa   Lactobacillus ruminis 
15.tttatctgctctctggctactttcaacac   Homo sapiens 
16.gcgtgggtgttgggctttttattgcgttat   - 
17.cttgcaaagtgtagtgtgttacacctta   Faecalibacterium prausnitzii  
18.attgtcaaaacataagcagctgcttcaaatatc  FN3523_1009 
 
Ft. novicida GA99-3548 (29 bp) 
1. atggattattacttaactggagtgtttac   FN3523_0992 
 
F. philomiragia (27-31 bp)  
1. atctcatttagaaattcaatttttaaattct   Fphi1603 (antisense) 
2. aaccctaaagattctaacggtgttatt   - 
3. gaaatggtggagtaatgccaagcaacg   - 
4. ggactattcttttaatgtttgatacata   - 
5. acttgatactatatgtacgaacatttagaa   Acinetobacter baumannii 
___________________________________________________________________________ 
Blastn results of selected sequences exhibiting <25 identical base pairs. 
Sequences underlined were found within the nucleotide sequence of the Ft. novicida phage. FN3523_ 





Table. 1 Genome sequences (species) used for CRISPR/Cas analysis 
Species Acession number CRISPR-1 CRISPR-2 
Ft. novicida U112 CP000439 + + 
Ft. novicida FTG ABXZ01000001* 
ABXZ01000002* 
+ + 
Ft. novicida-like Fx1 CP002557 + + 
Ft. novicida-like GA99-3548 DS264589* 
DS264590* 
+ - 
Ft. novicida-like GA99-3549 DS264128* 
DS264129* 
+ + 
Ft. novicida-like 3523 CP002558 + - 
 
Ft. tularensis SchuS4 AJ749949 + - 
Ft. tularensis FSC198 AM286280 + - 
Ft. tularensis MA00-2987 DS990216* + ni 
Ft. tularensis WY96-3418 CP000608 +  - 
Ft. tularensis NE061598 CP001633.1 + - 
Ft. tularesnsis TIGB03 CP003048 + - 
Ft. tularensis TI0902 CP003049 + - 
Ft. holarctica LVS NC_007880 + - 
Ft. holarctica  FSC257 DS229056* + ni 
Ft. holarctica FSC022 DS264138* + ni 
Ft. holarctica FTNF002-00 CP000803 + - 
Ft. holarctica OSU18 CP000437 + - 
 
Ft. mediasiatica FSC147 CP000915 + - 
 
F. philomiragia ATCC25017 CP000937 - + 
F. philomiragia ATCC25015 DS99316* - - 
F. philomiragia TX077308 CP002872 - - 
F. noatunensis subsp. orientales CP003402 - - 
* contigs of shot gun sequences received from NCBI/GenBank/ "DBSource" 
ni= not investigated  
 
 
Table 2. Spacer sequences of CRISPR-1 (A) and CRIPR-2 (B) systems of various 
Francisella strains. 
 
A. CRISPR-1       Blastn (>25 bp in length) 
 
Ft .novicida U112 (34-37 bp)    
1. caagattggtatatatcaactgctaatcactcgc  - 
2. ggtaaaaccaaaaaccaaaagttaagatatctctt  - 
3. tatgcggcttgtggttgtgtcattgcgaagactg  - 
4. ttaagcggatcaatttcgattacatcttcaccagat  - 
5. tttgtcaaatattggtcgagttatcttaaatagt  Nostoc punctiforme pNPUN03 
6. actcctatatgaccatacaaaacctgcccattac  - 
7. ttatttgccaacactcaaaagataggtaaccctatag  - 
8. tagttttttattatctgtgctgttttctgtcattgc  - 
9. gtatatatcagtagtttaaaagcattggctattact  - 
10.gttaataatgctaaagaaccagctgaatgtgtaa  - 
11.attcttgaattaagtgttgctgctgaggattaggca  antisense of spacer 7 of Ft.
        nov. GA99-3549 (CRISPR-1)* 
12.atataaatttggataattttaaggtattaaatcctt  - 
13.atcacactataaaagtaatcaagcttgccattgt  - 
 
Ft. novicida Fx1 (34-37 bp) 
1. tctggatgtagtaaccaagtcttacgctcgataa   - 
2. gttggatctgtctctctcattaatacaagattgtat  - 
3. aataaagaaaatgtagacttattccaaaacgtta  - 
4. agcttctcatatatgtatttactgtcgatttgat  - 
5. ttttaataggtgatttgtgaattttgatgagttaaag  - 
 
Ft. novicida FTG (34-38 bp) 
1. aagtttgacttgttaccctttgaatttcatctcta  - 
2. tcaatataccagctaggattactcgcataagcat  - 
3. taatgcaaatttgtatagtctacttctgtagaataa  Xenopus tropicales mRNA, 
        Homo sapiens DNA 
4. agtattttctcttgtcttgtaagttctcttagatag  FN3523_0993 
5. taagaaacttcgtcggttcttgggtactatgtacta  - 
6. agtattcttgacgcggctactaatacgtatcaaataaa Flavobacterium   
        branchiophilum 
7. taaagcactctctaagatgacttcataattactac  - 
8. aacgatattacacgcgaaagagctgcttttgagat  FN3523_1002 
9. taagcaagactctcaaacagactttaaagcatcgttt  - 
10.gctctatttaagtgttcgtgatactctgtttgtaa  - 
11.acaagctaaagaaattattataattgcttactaca  - 
12.tagcaagtattagtttacttcatttatttaaaat  - 
13.agattatgtgtaagcaacttaattttaacgaacttc  - 
14.atctaattggtaactcggaaagtataatcattg  - 
15.acccaaataatctcgttatcatgaggctttatttg  - 
16.tcctgaaatttccactggtctcccaagaaagcttg  - 
17.ccgtatttagcctaatgttatctttaaatatttcaa  - 
18.aagaattaaaacaagaaagcatgtaacaaacttagat  M.truncatula DNA 
19.ctctttcttcccctttctgcttgtcgctcaataaa  - 
20 ttattagaaaaaataaatgctggtatgttaaaattcg  Homo sapiens DNA 
21.atcatagaagctaaatatagcggtaaaatgtttga  - 
22.ctctttcttcccctttctgcttgtcgctcaataaa  - 
 
Ft. novicida 3523 (34-37 bp) 
1. ttgccagtataaccaccttcagcaaaaccagtaaca  Acinetobacter baumannii 
        phage minor tail protein* 
2. gccaaaaagactgagcctaaggctaaagttgagg  - 
3. gtaataacagcctttgagcctttacagcctacaa  - 
4. ccagcactatctgcaattgcaatgttgctttggt  - 
5. attaaaaaagaaatatatgctgtatcgtatggca  - 
6. catataacctgaattgtacccgtatcggcagcag  - 
7. ttttttttatttgttttgcctgcaatgctcatagca  - 
8. taacgcctcgaagttgaactttataacccaatatag  - 
9. ttcatctaaccaatccccataatcgttccataattg  - 
10.tcgacatactcttgatattcattatctggcttaa  - 
11.aatatcgctagaaaacatattgttaagcatattat  - 
12.ccgtttcaacaacaggcttgaagtttcaagcact  - 
13.tcaccctcgccgccagtttgaccgcctccaccag  Symbiobacterium thermophilum 
14.aattgtgaaatagataatatagcttctacattaga  Mus musculus BAC clone 
15.ataaaaattaaataaaatatcttgaaatgcttatt  Felis catus 
16.agagaatttgtatttagataccctaagattaagaaaa  - 
17.tctggacgagtgttggttatagtcattgtcatacc  - 
 
Ft. novicida GA99-3548 (35-37 bp) 
1. tcgacaggagtctgaccgtcaattaaagcagataatc  - 
2. taggatttacgccagctaattcgttaactaggttca  - 
3. gaactcgtcgtacatgatctccgccgccatgtgcag  - 
4. cgctactataaataggggcggatataataaccgaa  - 
5. ttcatcagcgaatcttttaaatttcttagatttgtca  - 
6. gtacaaagagtttatttctcgtgttactttttttatt  Mus musculus BAC clone 
7. gcccaaattttctgctcaaattcgccttttttgcg  FN3523_0999 
8. tatcttcaatatacaaatcaatataagagttatct  FN3523_1006 
9. ctatattcaaacttgcatatatttctgatagggct  FN3523_1009 
10.attaattgcactagagaagcaagtccgaatctcggg  - 
 
Ft. novicida GA99-3549 (34-36 bp) 
1. aagatagacagagctttattacaatcaagaaaagat  - 
2. ccagttacgttatcgtctcgcactatcgcaggag  - 
3. aatcatagagttaatttcgctcctgaccctgctg  - 
4. tgattaataacacgataaacattacctttttgtttt  - 
5. aatgattaaaatctacgaaactgatactcaaattc  - 
6. agttgcctcgaatcgttccagcagatgtaaacat  - 
7. aacccgcaacagcaacacttaattcaagagttgg  antisense spacer 11 Ft. nov 
        U112 (CRISPR-1)* 
8. aaatctaaaaaatgtagattaataccaatacagcaa  B. subtilis plasmid 
 
 
B. CRISPR-2        Blastn (>22 bp in length) 
 
Ft. novicida U112 (26-32 bp)  
1. gagaagtcatttaataaggccactgttaaaa   - 
2. gctactattcctgtgccttcagataattca   Strongylocentrotus  
        purpuratus 
3. gtctagagccttttgtattagtagccg   - 
4. tagcgatttatgaaggtcattttttt    intergenic region  
        (FN3523_1004-5) 
5. agattaaaaggtaattctatcttgttgag   FN3523_0998 (antisense) 
6. tacctagtagatacgcttactgataacaa   - 
7. aaactttcatttatgatataaagtttttt   Apis mellifera, mRNA 
8. tcaaaaggcaagagagacggaaataaatggac   Sisymbrium irio, V. harveyi 
        plasmid 
9. ttgtttgattgcttgcattgaaccttgaa   16S rRNA 
 
Ft. novicida Fx1 (28-29 bp)  
1. gccatctcttcataataaccactccaaa   - 
2. taacatatggactggcatattcttccaa   - 
3. ctaacgtagcgtaataaccagtaagtagg   - 
4. ataagggtacgttcggtcaaatagctact   - 
5. aaacacttctgtcgttttttcaaacattt   - 
6. atggattattacttaactggagtgtttac   Fn 3523_0992  
 
 
Ft. novicida FTG (27-30 bp)  
1. tttttgtgtatgtaatgtagctttcttta   - 
2. atggttgtctaggtagtgtaaattccat   - 
3. aagcagctgcttatgttttgacaatcaaa   - 
4. tcaataaaaaatgcccattgactaacgg   - 
5. atattgttttaaatcgtcgctatcagcaaa   - 
6. caaatatagctaacttttggaactcag   - 
7. tctattatgtttcctgaaagagtagtttt   Naegleria gruberi, mRNA 
8. gccacaaatactacaaaaaataacttaa   FN3523_1005 
9. ctaggcttggaatatctgtcagagata   - 
 
Ft. novicida GA99-3549 (28-33 bp)  
1. ggctttctttagcttcttctagagtttt   C. perfringens purD 
2. atataactatcaccagcaatctgtacgag   Vibrio phage ICP1_2004_A 
3. taaaatggttgtttagttatgtcagaaat   Rattus norvegicus BAC clone 
4. aatttacgccgtatttcatttcatctcc   Drosophila melanogaster 
5. gcagagatcattaaaccaatagcacagc   - 
6. tctgtagaaattcctagtttttgagatg   Homo sapiens 
7. ggctcaagtaatatcaataatttagaat   - 
8. atttatgtgatgactggtgttgctaatg   - 
9. acaattatatccatcacatacccctctaa   Aciduliprofundum boonei 
10.tgtattttagataggtttcagcagaaat   - 
11.agtgcttaagaaaatcgaaagtatttggg   - 
12.tataatgaaaatacgattattacttagaag   - 
13.attgtcaaaacataagcagctgcttcaaatat   FN3523_1009 
14.gtcgctttatcatctttatactccttaa   Lactobacillus ruminis 
15.tttatctgctctctggctactttcaacac   Homo sapiens 
16.gcgtgggtgttgggctttttattgcgttat   - 
17.cttgcaaagtgtagtgtgttacacctta   Faecalibacterium prausnitzii  
18.attgtcaaaacataagcagctgcttcaaatatc  FN3523_1009 
 
Ft. novicida GA99-3548 (29 bp) 
1. atggattattacttaactggagtgtttac   FN3523_0992 
 
F. philomiragia (27-31 bp)  
1. atctcatttagaaattcaatttttaaattct   Fphi1603 (antisense) 
2. aaccctaaagattctaacggtgttatt   - 
3. gaaatggtggagtaatgccaagcaacg   - 
4. ggactattcttttaatgtttgatacata   - 
5. acttgatactatatgtacgaacatttagaa   Acinetobacter baumannii 
___________________________________________________________________________ 
*Blastn results of selected sequences exhibiting < 25 identical base pairs 
Sequences underlined were found within the nucleotide sequence of the Ft. novicida phage. 
FN3523_ and Fphi1603, gene number of Ft. novocida-like strain 3523 and F. philomiragia, 
respectively. 
 
FTN0757                               0758       0759     0760 
cas9_endonuclease                          cas1      cas2      cas4                          359 bp            37 bp      ~35 bp 




Cas-1 genes                                       Leader           DR   Spacer  DR A    Ft. novicida U112 
Fig. 1 
(13 x) 
Cas-2 genes                                 Leader           DR   Spacer  DR 
FTN1397                               1396          1395      1394                                             (#1)       (9 x)     (#L) 
hyp. protein                              cas4          cas1       cas2                   139 bp               36 bp     ~29 bp 
     (1300 aa)                          (163 aa)    (334 aa)   (90 aa) 
asrR 
829 bp 
B    Ft. novicida U112 
~6,650 bp 
Ac_TF 













































cas9_endonuclease                           cas1       cas2        cas4                 359 bp        37 bp   ~35 bp fopA 
Ft. nov U112 
Ft. nov-like 3523 
90% 
Ft. nov FTG FTG 1435                                         1436        1437     1438                                                                   1443 




ps-cas1                     (194 aa)               (453 bp) 
(194 aa) 
100% 
FN3523  1121                                    1120/19   1118    1117                                                                     1115 





Ft. hol FSC022 
                                                                             ps-0487     ps-0486   (200 aa)  
Ft. hol  257 
Ft. hol  LVS 
                                                         ps-cas1                        (190 aa) 
Ft. med FSC147 




                                                                  ps-1244                        (192 aa) 
FTHG1247 1246       1245                                 1243     1242  
FTL1327 1326    1325                 1323-22     1321    1320 
ps-IS-Ftu2 
ps-IS-Ftu2 










  (1123)                                                         ps-0585    ps-cas2  (192 aa)                                         
98% 
IS-Ftu2 
FTT      0584                                                     n.a     0586                                  
98% 99% 
Ft. nov Fx1 
98% 
FNF 0762                                        n.a                               0763                                                               0764  
                                                 ps  cas1                                   ps-cas4                                               5 x                             
Ft. nov GA99-3548 98% 
                                                             ps  cas1                                   ps-cas4                                               11 x                             
FTDG  0338                                  n.a                               0339                                                                0340  
99% 
99% 
Ft. nov GA99-3549 FTCG 0283                                         0284      0286                                                                               0287 
8 x ps-cas4-IS                   
97% 99% 
FTAG0491 0490 0498        0488                               0486    0485  
A. CRISPR/Cas-1,  DRs  
Ft.nov U112    ctaacagtagtttaccaaataattcagcaactgaaac 
Ft.nov FTG    ..................................... 
Ft.nov Fx1    ..................................... 
         (2.)    ......-----------.................... 
Ft.nov 3523    .......c...a..t........ct...t........ 
         (#L)    .......c...a..t........ct...t...t.t.a 
Ft.nov GA-48    ..................................... 
Ft.nov GA-49    ..................................... 
Ft.tul MA00    ..................................... 
Ft.tul Schu    ..................................... 
Ft.hol FSC022    ..................................... 
Ft.hol 257    ..................................... 
Ft.hol  LVS    ..................................... 
Ft.med FSC147    a.................................... 
 
 
B. CRISPR/Cas-2,  DRs 
#1 repeat 
Ft.nov U112    gtctaagaactttaaataatttctactgttgtagat 
Ft.nov Fx1    .................................... 
Ft.nov FTG    .................................... 
Ft.nov GA-49    .................................... 
Ft.nov GA-48*    ..a...c.............................  
Ft.tul Schu*    ..a...c.............................  
F.phi 25017    .................................... 
 
#L repeat 
Ft.nov U112    ......................g.ctgta.a.tat. 
Ft.nov Fx1    ......................g.ct.ta.a.tat. 
Ft.nov FTG    ......................gcctgta.a.tat. 
Ft.nov GA-49    c......................cctata.a.tat. 
Ft.nov GA-48*    ......................g.ct.ta.a.tat.  
Ft.nov 3523*    a.....c................gc.aa.atatt.. 
Ft.tul Schu*    ......t...............g.ct.ta.a.tat. 
F. phi 25017    ..........a.....a....c.gttaa.gtag.t. 
       
Fig. 4 
 (9 x) 
hyp. pr. (1300)           cas4 (163) cas1 (334)  cas2 (90)    139 bp     36 bp  ~29 bp   arsR              naoX 
Ft. nov U112 
Ft. nov Fx1 
Ft. nov FTG 
 (1307)                                                               (96)                                  (9 x, ~28bp)  
99% 
100% 
Ft. nov GA-49 99% 
(18 x) 
F. phi TX077308 
F. phi (ATCC25015) 
 F7308_1474           1473 „1472“   1471 
 FTPG_ 0261        0262   0263    0264 
Ft. tul SchuS4/hol LVS*  
Ft. nov 3523                                           (FN3523) 1453                 1                      1452      1451       1450 
 FTN1398                   1397                                     1396          1395         1394                                                                    1393      1392      1391 
FNF1432                    1431                                     1430          1429         1428                                                                     1427      1426      1425 
(184 aa)                                                                    (6 x)  
FTC0910                 0909                                        0908          0907           n.a                                                                     0906       0905      0904  
F. phi  ATCC25017 
AcTF    1291      1292    arsR               naoX 




 Fphi1649         1650       1651         1652              1653           1654        1655                                                                    1656  1657      1658 






 FTG0872                0873                                        0874           0875         0876                                                                    0877       0878     0879  
Ft. nov GA99-3548                                    (FTDG) 0962                                         0961      0960       0959 
 (1 x) 
Ft. mediasiatica                                          (FTM) 1464                                                               0596       0595       0594 
AcTF           IS-Ftu1                    naoX               arsR      IS-Ftu1 
AcTF                           arsR               naoX 
  AcTF 
0986:  197 aa, 2x internal repeat, hypothetical protein 
0987:  408 aa, phage_GPD, GpD, phage late control D protein 
0988:  66 aa, phage_tail_X, GpX 
0989:  138 aa, Phage_P2_GpU,  
0990:  607 aa, phage tail tape measure protein 
0991:  89 aa, Flu_Mu_gp41 
0992:  159 aa, phage, major tail tube protein,  
0993:  385 aa, tail sheath protein 
0994: 106 aa, hypothetical protein 
0995:  81 aa, hypothetical protein 
0996:  66 aa, hypothetical protein 
0997:  198 aa, phage_base_V, baseplate assembly GpV 
0998:  163 aa, putative phage-related protein 
0999:  166 aa, minor tail_Z 
1000:  111 aa,  
1001:  63 aa, putative phage-related protein 
1002:  600 aa, Peptidase_U35 + major Phage_capsid; (E. phage 
              vB_EcoM_ECO1230-10[~42.000 bp], dsDNA-virus ) 
1003:  473 aa, Phage_Portal_2, capsid protein, froming 
              DNA-ejection hole (lambda familie)  
1004:  88 aa, coiled-coil,  
1005:  110 aa, conserved hypothetical protein 
1006:  183 aa, putative phage protein 
1007:  324 aa, phage tail fiber protein 
1008:  195 aa, tail_P2_I, phage tail protein I 
FN3523_0985            0986                           0992             0998                          1005          1009                                       1018                         1026                         1033    1034 
34,259 bp 
HlyD 
Ft. novicida phage (48 ORFs) 
1009:  281 aa, baseplate_J 
1010:  112 aa, Gpw_gp25, phage baseplate, lysozym activity 
1011:  131 aa, 1x TM, coiled-coil 
1012:  196 aa, 1x TM 
1013:  602 aa, phage terminase GpA 
1014:  671 aa, (phage related) 
1015:  93 aa, virus coat protein 
1016:  172 aa,   FTG_0292 
10017 : 387 aa, FTG_0291 
1018:  422 aa, phage integrase,  
1019:  64 aa,  
1020:  72 aa,  
(n.a) :  87 aa, SP, coilded coil 
1021:  239 aa, phage rha gene, phage anti-repressor (circular form) 
1022:  120 aa, YopX_SF,putative chaperone 
1023:  100 aa, coiled-coil,  
1024:  85 aa,  
1025:  212 aa,  
1026:  240 aa, Phg_2220_C SF, putative phage replication protein 
1027:  56 aa, gp55, Cro EBPR podovirus 1  
1028:  265 aa, H-T-H XRE, pro-phage repressor 
1029:  293 aa,  
1030:  112 aa,  
1031:  264 aa, H-T-H,  
1032:  130 aa,  
1033:  375 aa, site-specific recombinase  
tRNA-Val 
tRNA-Val  ACTCGCATAGCTCAGTTGGTTAGAGTACTACCTTGACATGGTAGGGGTCACTGGTTCGAATCCAGTTGCGAGTACCA 
repeat-1                                CCTTGACATGGTAGGGGTCACTGGTTCGAATCCAGTTGCGAGTACCA 
                                                                              
Fig. 6 
A  
B  
